Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TJX Companies
TJX
|
+$34.8M |
| 2 |
Kinder Morgan
KMI
|
+$27.8M |
| 3 |
EOG Resources
EOG
|
+$27.5M |
| 4 |
Medtronic
MDT
|
+$27.1M |
| 5 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$42.7M |
| 2 |
Apple
AAPL
|
+$36.5M |
| 3 |
Comcast
CMCSA
|
+$33.5M |
| 4 |
CVS Health
CVS
|
+$30.9M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
+$29.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 19.53% |
| 2 | Technology | 15.96% |
| 3 | Consumer Discretionary | 14.59% |
| 4 | Healthcare | 13.04% |
| 5 | Consumer Staples | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Builders FirstSource
BLDR
$7.55B
| $2.33M | 0.06% |
190,403
-131,668
| -41% | -$2.97M |
|
377
Curtiss-Wright
CW
$23.5B
| $2.32M | 0.06% |
25,151
-125
| -0.5% | -$16K |
|
378
W.R. Berkley
WRB
$25.5B
| $2.32M | 0.06% |
100,001
+69,313
| +226% | +$2.06M |
|
379
Qiagen
QGEN
$9.1B
| $2.31M | 0.06% |
52,340
+28,924
| +124% | +$1.13M |
|
380
Chemours
CC
$2.4B
| $2.29M | 0.06% |
258,291
+240,556
| +1,356% | +$3.47M |
|
381
Integer Holdings
ITGR
$4.26B
| $2.29M | 0.06% |
36,365
-8,320
| -19% | -$679K |
|
382
Diodes
DIOD
$4.33B
| $2.25M | 0.06% |
55,396
-24,535
| -31% | -$1.18M |
|
383
Schneider National
SNDR
$6.28B
| $2.25M | 0.06% |
116,388
+33,620
| +41% | +$696K |
|
384
Union Pacific
UNP
$183B
| $2.23M | 0.06% |
15,830
-31,394
| -66% | -$5.19M |
|
385
Innospec
IOSP
$2.31B
| $2.23M | 0.06% |
32,119
-2,073
| -6% | -$189K |
|
386
Albany International
AIN
$1.68B
| $2.23M | 0.06% |
47,127
+641
| +1% | +$42K |
|
387
Loews
L
$22.5B
| $2.23M | 0.06% |
64,064
+52,832
| +470% | +$2.49M |
|
388
Coherus Oncology
CHRS
$219M
| $2.21M | 0.06% |
136,495
+14,012
| +11% | +$259K |
|
389
Royal Caribbean
RCL
$78.1B
| $2.21M | 0.06% |
+68,711
| New | +$6.28M |
|
|
AZPN
390
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $2.2M | 0.06% |
23,122
-73,096
| -76% | -$6.95M |
|
391
Amdocs
DOX
$6.41B
| $2.2M | 0.06% |
39,964
+12,937
| +48% | +$867K |
|
392
Teradyne
TER
$58.7B
| $2.19M | 0.06% |
40,427
-8,094
| -17% | -$514K |
|
393
TransUnion
TRU
$16.2B
| $2.19M | 0.06% |
33,013
-37,196
| -53% | -$3.21M |
|
|
VMRK
394
Vivmark Residential
VMRK
$25B
| $2.17M | 0.06% |
35,251
+14,359
| +69% | +$1.11M |
|
395
Bread Financial
BFH
$4.07B
| $2.16M | 0.06% |
80,547
+20,041
| +33% | +$1.36M |
|
396
Generac Holdings
GNRC
$12.2B
| $2.16M | 0.06% |
23,177
+17,434
| +304% | +$1.8M |
|
397
Keysight
KEYS
$53.8B
| $2.12M | 0.06% |
25,335
-55,707
| -69% | -$5.29M |
|
398
Haemonetics
HAE
$4.95B
| $2.12M | 0.06% |
21,266
+16,377
| +335% | +$1.78M |
|
399
Thomson Reuters
TRI
$45.7B
| $2.12M | 0.06% |
29,577
-32,822
| -53% | -$2.56M |
|
400
Humana
HUM
$45.5B
| $2.11M | 0.06% |
6,731
-37,588
| -85% | -$12.7M |
|
Similar funds
Joel Greenblatt's Q1 2020 Portfolio in Review
As of Q1 2020, Joel Greenblatt held 1,293 positions worth $3.6B, down 34% from $5.45B the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.
Joel Greenblatt withdrew a net $266M in Q1 2020, closing 238 positions and reducing 416 holdings. Its most notable exit was Johnson Controls International, an estimated $28.1M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Joel Greenblatt opened a new position in CONCHO RESOURCES INC. worth $16.6M.
- Joel Greenblatt's largest Q1 2020 buy was CONCHO RESOURCES INC.: 388,298 shares worth $16.6M.
- Joel Greenblatt added most to TJX Companies in Q1 2020, an estimated $34.8M increase.
- Joel Greenblatt's biggest Q1 2020 reduction was Bristol-Myers Squibb, cutting an estimated $42.7M.
- Joel Greenblatt fully exited Johnson Controls International in Q1 2020, selling an estimated $28.1M.
- Joel Greenblatt's ten largest holdings make up 9.7% of its $3.6B portfolio in Q1 2020.
- Joel Greenblatt opened 206 new positions and closed 238 in Q1 2020.
- Joel Greenblatt's portfolio value fell 34% quarter-over-quarter to $3.6B.
Based on Gotham Asset Management's 13F filing for Q1 2020, filed 15 May 2020.